Establishment Labs files prospectus supplement for resale of up to 2M common shares by selling shareholders

ESTABLISHMENT LABS HOLDINGS INC.

Prospectus supplement covers resale of up to 2,000,000 common shares, including shares issuable upon exercise of pre-funded warrants.
Selling shareholders include holders from Jan 9, 2024 securities purchase agreement; 1,101,565 shares and 898,435 warrant shares.
Registration statement on Form S-3 filed earlier; this is a takedown for existing shareholders' resale.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.